---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-030505"
form_type: "8-K"
ticker: "AMIX"
cik: "0001617867"
company_name: "Autonomix Medical, Inc."
filed_at: "2026-09-16T12:35:57+00:00"
generated_at: "2026-09-16T12:40:09.353495+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Autonomix Medical appoints former Medtronic Chief Regulatory Counsel Sandra Kalter to board

## Summary
- Board expanded from five to six members; Kalter appointed independent director effective Sept 14, 2026.
- Kalter spent 20 years at Medtronic, including VP and Chief Regulatory Counsel; oversaw due diligence for 27+ acquisitions.
- Her Medtronic work covered Symplicity Spyral renal denervation, Evolut TAVR, Micra TPS, and PulseSelect PFA systems.
- She receives standard non-employee director compensation; no committee assignments or disclosed conflicts reported.

## SEC filing metadata
- accession: 0001437749-26-030505
- form_type: 8-K
- ticker: AMIX
- cik: 0001617867
- company_name: Autonomix Medical, Inc.
- filed_at: 2026-09-16T12:35:57+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/0001437749-26-030505-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/amix20260914_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-030505
- JSON: https://secwatch.observer/filing/0001437749-26-030505.json
- Plain text: https://secwatch.observer/filing/0001437749-26-030505.txt

## Key facts
- Executive change
  Sandra Kalter was appointed as Independent Director at Autonomix Medical, Inc..
  - Action: appointed
  - Role: Independent Director
  source text: On September 14, 2026, Autonomix Medical, Inc. (the “Company”) Board of Directors (the “Board”) increased the size of the Board from five to six members and appointed Sandra Kalter as an independent member of the Company’s Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/0001437749-26-030505-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.